Journal Article (Review Article) DKFZ-2023-01798

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Prostate cancer-multiparametric MRI and alternative approaches in intervention and therapy planning.[Multiparametrische MRT und alternative Methoden in der Interventions- und Behandlungsplanung beim Prostatakarzinom].

 ;  ;  ;  ;  ;

2023
Springer Medizin New York]

Die Urologie 62(11), 1160-1168 () [10.1007/s00120-023-02190-6]
 GO

This record in other databases:

Please use a persistent id in citations: doi:

Abstract: In recent years, multiparametric magnetic resonance imaging (mpMRI) of the prostate has gained importance and plays a crucial role in both personalized diagnostics and increasingly in the treatment planning for patients with prostate cancer.The aim of this study is to present established and innovative applications of MRI in the diagnosis and treatment of localized prostate cancer, evaluating their strengths and weaknesses. Furthermore, it will explore alternative approaches and compare them in a comprehensive manner.A systematic literature review on the application of mpMRI for biopsy and therapy planning was conducted.The integration of modern imaging techniques, especially mpMRI, into the diagnostic algorithm has revolutionized prostate cancer diagnosis. MRI and MRI-guided biopsy detect more significant prostate cancer, with the potential to reduce unnecessary biopsies and the diagnosis of clinically insignificant carcinomas. In addition, MRI provides crucial information for risk stratification and treatment planning in prostate cancer patients, both before radical prostatectomy and during active surveillance.Multiparametric MRI offers significant added value for the diagnosis and treatment of localized prostate cancer. The advancement of MRI analysis, such as the implementation of artificial intelligence algorithms, holds the potential for further enhancing imaging diagnostics.

Keyword(s): Active surveillance ; Biopsy ; Quality assurance ; Risk stratification ; Ultrasonography

Classification:

Note: 2023 Nov;62(11):1160-1168

Contributing Institute(s):
  1. Personalisierte Früherkennung des Prostatakarzinoms (C130)
  2. E010 Radiologie (E010)
Research Program(s):
  1. 315 - Bildgebung und Radioonkologie (POF4-315) (POF4-315)

Appears in the scientific report 2023
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Springer ; DEAL Springer ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > E010
Public records
Publications database

 Record created 2023-09-05, last modified 2024-09-18



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)